Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

Hideaki Miyake, Norihisa Hanada, Hideo Nakamura, Shunsuke Kagawa, Toshiyoshi Fujiwara, Isao Hara, Hiroshi Eto, Kazuo Gohji, Soichi Arakawa, Sadao Kamidono, Hideyuki Saya

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

To investigate the effects of the expression of Bcl-2 protein in bladder cancer on the apoptosis induced by cisplatin or adenoviral-mediated p53 gene (Ad5CMV-p53) transfer, we transfected the bcl-2 gene into KoTCC-1, a human bladder cancer cell line that does not express the Bcl-2 protein. The Bcl-2-transfected KoTCC-1 (KoTCC-1/B) exhibited significantly higher resistance to both cisplatin and Ad5CMV-p53 transfer than did either the parental KoTCC-1 (KoTCC-1/P) or the vector-only transfected cell line (KoTCC-1/C). The flow cytometric analysis of the propidium iodide-stained nuclei and DNA fragmentation analysis after cisplatin or Ad5CMV-p53 treatment revealed DNA degradation in both KoTCC-1/P and KoTCC-1/C, whereas KoTCC1/B showed a marked inhibition of DNA degradation. Following the treatment with cisplatin or Ad5CMV-p53, the accumulation of p53 protein was highly detectable for a long period in KoTCC-1/B compared to that in KoTTC-1/P and KoTCC-1/C. Furthermore, the cisplatin and Ad5CMV-p53 treatments each reduced the volume of the subcutaneous tumors established in nude mice formed by KoTCC-1/P or KoTCC-1/C; in contrast, their reductive effects on the tumors formed by KoTCC-1/B were significantly suppressed. The intraperitoneal tumor cell implantation model revealed that the prognoses of mice injected with KoTCC-1/B were significantly inferior to those of the mice injected with either KoTCC-1/P or KoTCC-1/C after treatment with cisplatin or Ad5CMV-p53. These findings suggest that the expression of Bcl-2 in bladder cancer cells interferes with the therapeutic effects of cisplatin and Ad5CMV-p53 through the inhibition of the apoptotic pathway.

Original languageEnglish
Pages (from-to)933-943
Number of pages11
JournalOncogene
Volume16
Issue number7
Publication statusPublished - 1998 Feb 19
Externally publishedYes

Fingerprint

p53 Genes
Urinary Bladder Neoplasms
Cisplatin
Apoptosis
bcl-2 Genes
Cell Line
Proteins
Propidium
DNA
Therapeutic Uses
DNA Fragmentation
Tumor Burden
Nude Mice
Neoplasms

Keywords

  • Adenoviral-mediated p53 gene transfer
  • Apoptosis
  • Bcl-2
  • Bladder cancer
  • Cisplatin

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Miyake, H., Hanada, N., Nakamura, H., Kagawa, S., Fujiwara, T., Hara, I., ... Saya, H. (1998). Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene, 16(7), 933-943.

Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. / Miyake, Hideaki; Hanada, Norihisa; Nakamura, Hideo; Kagawa, Shunsuke; Fujiwara, Toshiyoshi; Hara, Isao; Eto, Hiroshi; Gohji, Kazuo; Arakawa, Soichi; Kamidono, Sadao; Saya, Hideyuki.

In: Oncogene, Vol. 16, No. 7, 19.02.1998, p. 933-943.

Research output: Contribution to journalArticle

Miyake, H, Hanada, N, Nakamura, H, Kagawa, S, Fujiwara, T, Hara, I, Eto, H, Gohji, K, Arakawa, S, Kamidono, S & Saya, H 1998, 'Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer', Oncogene, vol. 16, no. 7, pp. 933-943.
Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I et al. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene. 1998 Feb 19;16(7):933-943.
Miyake, Hideaki ; Hanada, Norihisa ; Nakamura, Hideo ; Kagawa, Shunsuke ; Fujiwara, Toshiyoshi ; Hara, Isao ; Eto, Hiroshi ; Gohji, Kazuo ; Arakawa, Soichi ; Kamidono, Sadao ; Saya, Hideyuki. / Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. In: Oncogene. 1998 ; Vol. 16, No. 7. pp. 933-943.
@article{75d155f3b632480584c8ac0ea3cfb08d,
title = "Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer",
abstract = "To investigate the effects of the expression of Bcl-2 protein in bladder cancer on the apoptosis induced by cisplatin or adenoviral-mediated p53 gene (Ad5CMV-p53) transfer, we transfected the bcl-2 gene into KoTCC-1, a human bladder cancer cell line that does not express the Bcl-2 protein. The Bcl-2-transfected KoTCC-1 (KoTCC-1/B) exhibited significantly higher resistance to both cisplatin and Ad5CMV-p53 transfer than did either the parental KoTCC-1 (KoTCC-1/P) or the vector-only transfected cell line (KoTCC-1/C). The flow cytometric analysis of the propidium iodide-stained nuclei and DNA fragmentation analysis after cisplatin or Ad5CMV-p53 treatment revealed DNA degradation in both KoTCC-1/P and KoTCC-1/C, whereas KoTCC1/B showed a marked inhibition of DNA degradation. Following the treatment with cisplatin or Ad5CMV-p53, the accumulation of p53 protein was highly detectable for a long period in KoTCC-1/B compared to that in KoTTC-1/P and KoTCC-1/C. Furthermore, the cisplatin and Ad5CMV-p53 treatments each reduced the volume of the subcutaneous tumors established in nude mice formed by KoTCC-1/P or KoTCC-1/C; in contrast, their reductive effects on the tumors formed by KoTCC-1/B were significantly suppressed. The intraperitoneal tumor cell implantation model revealed that the prognoses of mice injected with KoTCC-1/B were significantly inferior to those of the mice injected with either KoTCC-1/P or KoTCC-1/C after treatment with cisplatin or Ad5CMV-p53. These findings suggest that the expression of Bcl-2 in bladder cancer cells interferes with the therapeutic effects of cisplatin and Ad5CMV-p53 through the inhibition of the apoptotic pathway.",
keywords = "Adenoviral-mediated p53 gene transfer, Apoptosis, Bcl-2, Bladder cancer, Cisplatin",
author = "Hideaki Miyake and Norihisa Hanada and Hideo Nakamura and Shunsuke Kagawa and Toshiyoshi Fujiwara and Isao Hara and Hiroshi Eto and Kazuo Gohji and Soichi Arakawa and Sadao Kamidono and Hideyuki Saya",
year = "1998",
month = "2",
day = "19",
language = "English",
volume = "16",
pages = "933--943",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

AU - Miyake, Hideaki

AU - Hanada, Norihisa

AU - Nakamura, Hideo

AU - Kagawa, Shunsuke

AU - Fujiwara, Toshiyoshi

AU - Hara, Isao

AU - Eto, Hiroshi

AU - Gohji, Kazuo

AU - Arakawa, Soichi

AU - Kamidono, Sadao

AU - Saya, Hideyuki

PY - 1998/2/19

Y1 - 1998/2/19

N2 - To investigate the effects of the expression of Bcl-2 protein in bladder cancer on the apoptosis induced by cisplatin or adenoviral-mediated p53 gene (Ad5CMV-p53) transfer, we transfected the bcl-2 gene into KoTCC-1, a human bladder cancer cell line that does not express the Bcl-2 protein. The Bcl-2-transfected KoTCC-1 (KoTCC-1/B) exhibited significantly higher resistance to both cisplatin and Ad5CMV-p53 transfer than did either the parental KoTCC-1 (KoTCC-1/P) or the vector-only transfected cell line (KoTCC-1/C). The flow cytometric analysis of the propidium iodide-stained nuclei and DNA fragmentation analysis after cisplatin or Ad5CMV-p53 treatment revealed DNA degradation in both KoTCC-1/P and KoTCC-1/C, whereas KoTCC1/B showed a marked inhibition of DNA degradation. Following the treatment with cisplatin or Ad5CMV-p53, the accumulation of p53 protein was highly detectable for a long period in KoTCC-1/B compared to that in KoTTC-1/P and KoTCC-1/C. Furthermore, the cisplatin and Ad5CMV-p53 treatments each reduced the volume of the subcutaneous tumors established in nude mice formed by KoTCC-1/P or KoTCC-1/C; in contrast, their reductive effects on the tumors formed by KoTCC-1/B were significantly suppressed. The intraperitoneal tumor cell implantation model revealed that the prognoses of mice injected with KoTCC-1/B were significantly inferior to those of the mice injected with either KoTCC-1/P or KoTCC-1/C after treatment with cisplatin or Ad5CMV-p53. These findings suggest that the expression of Bcl-2 in bladder cancer cells interferes with the therapeutic effects of cisplatin and Ad5CMV-p53 through the inhibition of the apoptotic pathway.

AB - To investigate the effects of the expression of Bcl-2 protein in bladder cancer on the apoptosis induced by cisplatin or adenoviral-mediated p53 gene (Ad5CMV-p53) transfer, we transfected the bcl-2 gene into KoTCC-1, a human bladder cancer cell line that does not express the Bcl-2 protein. The Bcl-2-transfected KoTCC-1 (KoTCC-1/B) exhibited significantly higher resistance to both cisplatin and Ad5CMV-p53 transfer than did either the parental KoTCC-1 (KoTCC-1/P) or the vector-only transfected cell line (KoTCC-1/C). The flow cytometric analysis of the propidium iodide-stained nuclei and DNA fragmentation analysis after cisplatin or Ad5CMV-p53 treatment revealed DNA degradation in both KoTCC-1/P and KoTCC-1/C, whereas KoTCC1/B showed a marked inhibition of DNA degradation. Following the treatment with cisplatin or Ad5CMV-p53, the accumulation of p53 protein was highly detectable for a long period in KoTCC-1/B compared to that in KoTTC-1/P and KoTCC-1/C. Furthermore, the cisplatin and Ad5CMV-p53 treatments each reduced the volume of the subcutaneous tumors established in nude mice formed by KoTCC-1/P or KoTCC-1/C; in contrast, their reductive effects on the tumors formed by KoTCC-1/B were significantly suppressed. The intraperitoneal tumor cell implantation model revealed that the prognoses of mice injected with KoTCC-1/B were significantly inferior to those of the mice injected with either KoTCC-1/P or KoTCC-1/C after treatment with cisplatin or Ad5CMV-p53. These findings suggest that the expression of Bcl-2 in bladder cancer cells interferes with the therapeutic effects of cisplatin and Ad5CMV-p53 through the inhibition of the apoptotic pathway.

KW - Adenoviral-mediated p53 gene transfer

KW - Apoptosis

KW - Bcl-2

KW - Bladder cancer

KW - Cisplatin

UR - http://www.scopus.com/inward/record.url?scp=15444340598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15444340598&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 933

EP - 943

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 7

ER -